Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Medpace Holdings Inc (NASDAQ: MEDP) closed the day trading at $282.28 down -2.32% from the previous closing price of $288.99. In other words, the price has decreased by -$2.32 from its previous closing price. On the day, 1.82 million shares were traded. MEDP stock price reached its highest trading level at $285.37 during the session, while it also had its lowest trading level at $250.05.
Ratios:
For a better understanding of MEDP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.91. For the most recent quarter (mrq), Quick Ratio is recorded 0.93 and its Current Ratio is at 0.93. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.15.
On April 14, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy but kept the price unchanged to $328.
On March 24, 2025, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $330.Leerink Partners initiated its Market Perform rating on March 24, 2025, with a $330 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 27 ’25 when EWALD STEPHEN P bought 2 shares for $326.11 per share. The transaction valued at 652 led to the insider holds 13,343 shares of the business.
Carley Brian T sold 4,003 shares of MEDP for $1,383,397 on Feb 24 ’25. The Director now owns 26,032 shares after completing the transaction at $345.59 per share. On Feb 24 ’25, another insider, Carley Brian T, who serves as the Director of the company, bought 4,003 shares for $345.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MEDP now has a Market Capitalization of 8422162432 and an Enterprise Value of 8107389440. As of this moment, Medpace’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.34, and their Forward P/E ratio for the next fiscal year is 21.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.52. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.05 while its Price-to-Book (P/B) ratio in mrq is 10.45. Its current Enterprise Value per Revenue stands at 3.759 whereas that against EBITDA is 16.699.
Stock Price History:
The Beta on a monthly basis for MEDP is 1.51, which has changed by -0.2899688 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, MEDP has reached a high of $459.77, while it has fallen to a 52-week low of $271.99. The 50-Day Moving Average of the stock is -11.58%, while the 200-Day Moving Average is calculated to be -18.66%.
Shares Statistics:
Over the past 3-months, MEDP traded about 438.80K shares per day on average, while over the past 10 days, MEDP traded about 854680 shares per day. A total of 30.56M shares are outstanding, with a floating share count of 24.48M. Insiders hold about 19.01% of the company’s shares, while institutions hold 85.68% stake in the company. Shares short for MEDP as of 1743379200 were 1393087 with a Short Ratio of 3.17, compared to 1740700800 on 1463684. Therefore, it implies a Short% of Shares Outstanding of 1393087 and a Short% of Float of 5.7299999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
